533 related articles for article (PubMed ID: 17062247)
1. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
3. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
[TBL] [Abstract][Full Text] [Related]
4. Treatment of refractory bleeding after cardiac operations with low-dose recombinant activated factor VII (NovoSeven): a propensity score analysis.
Gelsomino S; Lorusso R; Romagnoli S; Bevilacqua S; De Cicco G; Billè G; Stefàno P; Gensini GF
Eur J Cardiothorac Surg; 2008 Jan; 33(1):64-71. PubMed ID: 17996457
[TBL] [Abstract][Full Text] [Related]
5. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
[TBL] [Abstract][Full Text] [Related]
6. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
Gong ZY; Gao CQ; Xiao CS; Li BJ; Ma XH; Zhang CM
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1497-501. PubMed ID: 19094631
[TBL] [Abstract][Full Text] [Related]
7. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
11. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
[TBL] [Abstract][Full Text] [Related]
12. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
13. Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes.
Uber WE; Toole JM; Stroud MR; Haney JS; Lazarchick J; Crawford FA; Ikonomidis JS
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1469-77.e2. PubMed ID: 21457998
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
15. A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Murkin JM
Can J Anaesth; 2002 Dec; 49(10):S21-6. PubMed ID: 12546007
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
[TBL] [Abstract][Full Text] [Related]
17. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
18. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Tomita E; Takase H; Tajima K; Suematsu Y
Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
[TBL] [Abstract][Full Text] [Related]
19. [The use of recombinant activated factor VIIa for major bleedings in open heart surgery].
Ingimarsson JP; Onundarson PT; Valsson F; Vidarsson B; Gudbjartsson T
Laeknabladid; 2008 Sep; 94(9):607-12. PubMed ID: 18784387
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
